Overview
CLL
?
Sunil Kumar Choksi
See more contacts
Medical and Diagnostic Laboratories
,
Other Support Services
,
Architectural, Engineering, and Related Services
,
Testing laboratories
,
Business services, nec
See All Industries Product testing laboratories
See Fewer Industries
See All Industries Product testing laboratories
See Fewer Industries
Child Care Services
,
Community Food and Housing, and Emergency and Other Relief Services
,
Continuing Care Retirement Communities and Assisted Living Facilities for the Elderly
,
General Medical and Surgical Hospitals
,
Home Health Care Services
,
Individual and Family Services
,
Nursing Care Facilities (Skilled Nursing Facilities)
,
Offices of Dentists
View more , Offices of Other Health Practitioners , Offices of Physicians , Other Ambulatory Health Care Services , Other Residential Care Facilities , Outpatient Care Centers , Psychiatric and Substance Abuse Hospitals , Residential Intellectual and Developmental Disability, Mental Health, and Substance Abuse Facilities , Specialty (except Psychiatric and Substance Abuse) Hospitals Vocational Rehabilitation Services
View fewer
View more , Offices of Other Health Practitioners , Offices of Physicians , Other Ambulatory Health Care Services , Other Residential Care Facilities , Outpatient Care Centers , Psychiatric and Substance Abuse Hospitals , Residential Intellectual and Developmental Disability, Mental Health, and Substance Abuse Facilities , Specialty (except Psychiatric and Substance Abuse) Hospitals Vocational Rehabilitation Services
View fewer
?
?
?
Actual
?
Actual
$4.43 million
Actual
6.55%
-65.43%
$619
MAR
?
?
Bombay:526546
Contacts
Get in Touch with 8 Principals* and 4 Contacts
-
Sunil Kumar ChoksiManaging Director
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of March 31, 2024 (12 month period) in USD
Annual Revenue 2024
$4.43 million
USD
Actual
1 USD = 82.8981 INR
All financial statement data is in millions except per share data | Source: Morningstar
Cash Flow (mil) | 2024 | 2023 | 2022 |
---|---|---|---|
Net Operating Cash | $1 | $1 | $1 |
Net Investing Cash | -$1 | -$0 | -$0 |
Net Financing Cash | -$1 | -$1 | -$1 |
Net Change in Cash | $0 | -$0 | $0 |
Cash at Beginning of Period | $0 | $0 | $0 |
Cash at End of Period | $0 | $0 | $0 |
Capital Expenditure | -$1 | -$1 | -$0 |
Assets (mil) | 2024 | 2023 | 2022 |
---|---|---|---|
Current Assets | |||
Cash and Cash Equivalents | $0 | $0 | $0 |
Accounts Receivable | $1 | $1 | $1 |
Inventories | $0 | $0 | $0 |
Other Current Assets | $0 | $0 | $0 |
Asset Summary | |||
Total Current Assets | $2 | $2 | $2 |
Tangible Fixed Assets | $6 | $5 | $6 |
Intangible Assets | $0 | $0 | $0 |
Total Assets | $620 | $604 | $644 |
Liabilities (mil) | 2024 | 2023 | 2022 |
---|---|---|---|
Current Liabilities | |||
Accounts Payable | $0 | $0 | $0 |
Short-Term Debt | $1 | $1 | $1 |
Other Current Liabilities | $0 | $0 | $1 |
Liability Summary | |||
Total Current Liabilities | $2 | $2 | $2 |
Long-Term Debt | $2 | $3 | $3 |
Other Long-Term Liabilities | -$0 | -$0 | $ |
Total Liabilities | $5 | $5 | $6 |
Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
---|---|---|---|
Equity | |||
Common Stock | $1 | $1 | $1 |
Retained Earnings | $2 | $1 | $1 |
Equity Summary | |||
Total Equity | $3 | $3 | $2 |
Shares Outstanding | 6,965,263 | 6,965,263 | 6,965,263 |